August 2026– date –
-
Reinste Highlights Hexagonal Boron Nitride (hBN) Revolutionizing LED Thermal Management for Enhanced Efficiency and Reliability
Reinste International Overview Reinste's guide emphasizes the potential of hexagonal boron nitride (hBN) to revolutionize thermal management in LED lighting systems, achieving efficient heat dissipation through its high thermal conductiv... -
Electrospun Nanofiber Scaffolds Offer Versatile 3D Structures for Tissue Regeneration, Overcoming Autograft Limitations in Bone Repair
JMST China Overview Electrospun nanofiber scaffolds are demonstrating promising advancements in diverse tissue engineering applications by mimicking the native extracellular matrix with their unique 3D network structures. This technology... -
3D Bioprinting Innovator Partners with MedTech Giant to Commercialize Regenerative Therapies
Specialized Media / Company Announcement USA Overview A pioneering 3D bioprinting company has announced a strategic licensing agreement with a leading medical device manufacturer, targeting the regenerative medicine sector. This partners... -
BioCentury Analyzes Commercialization Strategies for Gene-Edited Hematopoietic Stem Cell Therapies, Discussing Solutions for High Costs and Manufacturing Complexity
BioCentury USA Overview BioCentury published an analytical article focusing on commercialization strategies for companies developing gene-edited hematopoietic stem cell (HSC) therapies. The article discusses high treatment costs, manufac... -
ClinicalTrials.gov Updates Phase 2 Trial Registration for iPSC-Derived Retinal Pigment Epithelium Cell Transplantation for Age-Related Macular Degeneration
ClinicalTrials.gov USA Overview Information regarding a Phase 2 clinical trial for iPSC-derived Retinal Pigment Epithelium (RPE) cell transplantation targeting Age-related Macular Degeneration (AMD) has been updated or newly registered o... -
Japan’s Reprocell and University Announce Joint Development of iPSC Differentiation Protocol, Enhancing Cell Therapy Product Uniformity and Scalability
Reprocell / University Announcement Japan Overview Japanese regenerative medicine company Reprocell, in collaboration with a prominent university research lab, announced the joint development of a novel protocol for high-efficiency diffe... -
Exosome Therapeutics Firm Unveils Advanced Platform, Pipeline Progress Targeting Regenerative Medicine and Enhanced Drug Delivery
Company Disclosures USA Overview An exosome-based therapeutics company has detailed significant pipeline advancements and its cutting-edge technology platform at a recent investor briefing. The presentation particularly emphasized exosom... -
Automated GMP Facility Launched, Supercharging Scalable Production for Off-the-Shelf Cell Therapies
Company Announcement / Specialized Media International Overview A new, state-of-the-art GMP facility dedicated to commercial-scale allogeneic cell therapy manufacturing has commenced operations. This facility leverages advanced automatio... -
Pharma Giant Acquires Gene-Editing Pioneer, Bolstering Pipeline and Redefining R&D
Specialized Media USA Overview A leading pharmaceutical company has acquired a smaller biotechnology firm specializing in innovative gene-editing platforms. This strategic move aims to integrate cutting-edge gene therapy modalities into ... -
FDA Bestows RMAT Status on iPSC-Derived Cell Therapy for Intractable Disease, Poised to Accelerate Clinical Development
Company Announcement / Specialized Media USA Overview A regenerative medicine firm has announced its iPSC-derived cell therapy program for an intractable disease has received Regenerative Medicine Advanced Therapy (RMAT) designation from...
